02/14/2025
8:44 AM | Legend Biotech (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025
3:01 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2025
2:14 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
8:48 AM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
8:59 AM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:01 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024
6:35 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024
2:08 PM | Heyman Tomas J. (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
7:46 AM | Legend Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/12/2024
6:03 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for LEGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. |
11/05/2024
8:10 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
3:35 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
2:30 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:43 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
9:46 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
7:01 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2024
6:01 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/26/2024
6:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
3:32 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
3:25 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
4:00 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
6:01 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
12:06 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024
6:29 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
6:03 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
11:18 AM | BlackRock Inc. (Filed by)
Legend Biotech (Subject)
| Form SC 13G/A | |
03/29/2024
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
4:22 PM | Ji Darren Xiaohui (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:57 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
10:09 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:57 AM | Legend Biotech (Filer)
| Form F-3ASR | |
03/19/2024
6:02 AM | Legend Biotech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/15/2024
2:18 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024
7:36 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
6:52 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This Crypto Is Set to Explode in February (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
